← Back to Search

Procedure

Antibiotic Usage for Overactive Bladder

N/A
Recruiting
Led By Kathleen Kobashi, MD
Research Sponsored by Benaroya Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 14-30 days
Awards & highlights

Study Summary

This trial is testing whether it's necessary to give patients antibiotics before a procedure to treat overactive bladder.

Eligible Conditions
  • Overactive Bladder
  • Urinary Tract Infection
  • Antibiotic Stewardship
  • Botox

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~14-30 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 14-30 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Urinary tract infection
Secondary outcome measures
Percentage of subjective improvement in overactive bladder symptoms
Rate of adverse events including dysuria, gross hematuria, and urinary retention

Trial Design

2Treatment groups
Experimental Treatment
Group I: Prophylactic antibioticExperimental Treatment2 Interventions
These patients will receive the current standard of care, which is to receive a single dose of prophylactic antibiotics just prior to receiving intravesical injection of Onabotulinumtoxin A via cystoscopy. The specific prophylactic antibiotics will vary depending on patient's prior urine culture sensitivities and patient medication allergies/sensitivities and medical comorbidities.
Group II: No antibioticsExperimental Treatment2 Interventions
These patients will receive no prophylactic antibiotics prior to receiving intravesical injection of Onabotulinumtoxin A via cystoscopy.

Find a Location

Who is running the clinical trial?

Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction (SUFU)UNKNOWN
Stony Brook UniversityOTHER
213 Previous Clinical Trials
39,327 Total Patients Enrolled
Northwell HealthOTHER
458 Previous Clinical Trials
470,733 Total Patients Enrolled

Media Library

cystoscopic injection of onabotulinumtoxinA (Procedure) Clinical Trial Eligibility Overview. Trial Name: NCT04754737 — N/A
Overactive Bladder Research Study Groups: Prophylactic antibiotic, No antibiotics
Overactive Bladder Clinical Trial 2023: cystoscopic injection of onabotulinumtoxinA Highlights & Side Effects. Trial Name: NCT04754737 — N/A
cystoscopic injection of onabotulinumtoxinA (Procedure) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04754737 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the scope of this clinical trial in terms of participant numbers?

"Yes, the official records on clinicaltrials.gov specify that this study is actively recruiting for participants. The initial posting was made on March 23rd 2021 and it has been recently refreshed on July 21st 2022. 200 volunteers are needed from 1 site to fill out the trial's requirements."

Answered by AI

Are there any vacancies available in this clinical research project?

"Affirmative. Clinicaltrials.gov demonstrates that sign-up for this medical trial commenced on March 23rd 2021 and the post was last amended on July 21st 2022. The research is searching for 200 candidates to be drawn from 1 location."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Antibiotic Usage Prior to OnabotulinumtoxinA Injection
2021. "Antibiotic Usage Prior to OnabotulinumtoxinA Injection". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04754737.
~50 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top